HIT Consultant April 17, 2024
What You Should Know:
– When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to failed regulatory processes, or worse, consumer health being put in danger.
– Isospec Analytics has raised $1.9M to commercialize new technologies for molecular analysis that rapidly identify unknown molecules in minutes, helping pharmaceuticals, nutrition and agritech companies develop safer products and enabling researchers to discover new biomarkers.
Isospec: Redefining Molecular Analysis for Breakthroughs in Biotech
Founderful (formerly Wingman Ventures) leads Isospec’s $1.9M pre-seed round, joined by specialized investors Tiny.vc, another.vc, and Venture Kick.
Founded in 2022 by Ahmed Ben Faleh, Stephan Warnke, and Thomas Rizzo,...
Today's Sponsors
Today's Sponsor